Drug Database
Back to search

Japan· JP-6419006F1024

スピラマイシン

A spiramycin product containing スピラマイシン, registered in Japan by サノフィ, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

On Japan’s NHI price listATC J01FA02

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedスピラマイシンATCJ01FA02REGISTER NO.JP-6419006F1024PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about スピラマイシンAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Spiramycin is registered in 9 of 19 countries.

Countries holding a registration under ATC J01FA02 (spiramycin), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 6 of them publish a price we can compare per daily dose
Search spiramycin products by name

Spiramycin · ATC J01FA02

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
スピラマイシン
Manufacturer
サノフィ
Country
Japan (JP)
ATC code
J01FA02
ATC class
Spiramycin
Defined daily dose
3 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for spiramycin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check spiramycin against other medicinesHow interaction checks work

Spiramycin · interactions on record

5 records

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under J01FA02

Spiramycin, as other registers publish it.

All spiramycin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cdf8badb-26da-4fe4-b618-6dfa48bd8e39
GET /v1/drugs/cdf8badb-26da-4fe4-b618-6dfa48bd8e39?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１５０万国際単位１錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "6419006F1024",
  "category": "内用薬",
  "price_yen": 228.8,
  "generic_name": "スピラマイシン",
  "product_name_jp": null,
  "therapeutic_class": "6419",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about spiramycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console